InvestorsHub Logo
Followers 4
Posts 398
Boards Moderated 0
Alias Born 06/21/2006

Re: rod5247 post# 3946

Tuesday, 05/19/2015 3:46:05 PM

Tuesday, May 19, 2015 3:46:05 PM

Post# of 8524
I just got a chance to listen to HT at UBS. She stated the stage 1 202 study analysis that was presented to the FDA in Feb included ORR, PFS and OS. I expect that is the data that was submitted to ASCO. They had OS in time for an ordinary submission. No need for late breaking...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News